Scottsdale Research Institute has applied to the Drug Enforcement Administration to become an importer of basic classes of controlled substances for clinical research. Specifically, they plan to bring in synthetic cannabidiol for use by Schedule I researchers. People interested in this application can submit comments or request a hearing by May 19, 2025. The application does not include permission for importing substances for commercial sale.
Simple Explanation
Scottsdale Research Institute wants permission from the government to bring in special medicine from other countries to study it in research projects, but they can't sell it. People can say what they think about this plan until May 19, 2025.